LPL Financial’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
Other funds holding EBS
OHA
LPL Financial's EBS Position: Q2 2026 in Review
LPL Financial reduced its Emergent Biosolutions (EBS) stake by 2.4% in Q2 2026, selling an estimated $13.5K and leaving 64,896 shares worth $544K. The position accounts for ﹤0.01% of the portfolio, ranked #4950.
LPL Financial first reported a position in EBS in Q2 2015 and has held it in 17 quarters since. The position peaked at $1.39M in Q3 2020. 195 funds tracked by Wall St. Rank hold EBS as of Q2 2026.
- LPL Financial held 64,896 shares of Emergent Biosolutions worth $544K as of Q2 2026.
- LPL Financial sold 1,617 Emergent Biosolutions shares in Q2 2026, an estimated $13.5K.
- Emergent Biosolutions made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #4950 holding.
- LPL Financial first reported a position in Emergent Biosolutions in Q2 2015 and has held it in 17 quarters since.
- LPL Financial's Emergent Biosolutions position peaked at $1.39M in Q3 2020.
- 195 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.
Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.